Navigation Links
Cyberkinetics Requests FDA to Sell Nerve Growth Stimulation System

Cyberkinetics, Inc, winner of the Medgadget "Most Sci-Fi Sounding Company Name" Award, has asked the FDA for permission to market// their Andara OFS nerve growth stimulation system.

According to Cyberkinetics, “Cyberkinetics' Andara? OFS? System consists of a battery-powered device about the size of a cardiac pacemaker with six electrical leads. Three of the leads are attached to the vertebrae at a distance of two disk-segments above the area of injury, and three are attached to the vertebrae at a distance of two disk-segments below the injury. By applying an oscillating, low-voltage, direct current of electricity to the areas above and below a spinal cord injury, the Andara? OFS? System creates an electrical field that surrounds the injury and stimulates the nerves surrounding the spinal cord to grow and form new connections that can restore sensory and motor function. The Andara? OFS? System is an investigational device. It is not currently approved for sale and is available only through participation in a clinical study.

Cyberkinetics has filed an application for Humanitarian Use Device status from the FDA. If the application is successful, Cyberkinetics could market the device commercially in late 2007.

Basically, the new humanitarian exemption would mean that they could actually sell the device, rather than only use it through clinical trials.

Source-Bio-Bio Technology

Page: 1

Related medicine news :

1. Canadian Street Prostitutes Requests Protection
2. New Zealand Requests Details from Britain about ‘Black Sheep
3. Patients Requests for Antidepressants can Influence Physician Evaluation of Depression
4. FDA Requests Label Change for All Sleep Disorder Drug Products
5. Epilepsy Drug Helps Diabetic Nerve Damage
6. World’s First Nerve Stem Cells Produced
7. Children With Epilepsy Can Be Treated With Nerve Stimulation
8. FDA Approved Nerve-Stimulation Therapy Now Available In New York
9. Doctors Finish Mother-To-Son Nerve Surgery
10. Stem Cells From Hair Follicle To Repair Nerve Damage
11. Nerve regeneration for Spinal cord injuries
Post Your Comments:

(Date:11/29/2015)... ... ... Key Housing, a top-rated corporate housing service for the San Jose and ... In showcasing this featured apartment community in San Jose, Key Housing is helping those ... find housing suitable to their needs by showcasing quality housing. , “San Jose many ...
(Date:11/28/2015)... , ... November 28, 2015 , ... Beginning November 30th at 6:00 a.m. EST until ... most savings. , With possible savings of up to 20% off orders $80 or more ... of the website every few hours. , As a competitive e-commerce website for skin care ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published November ... and the University of British Columbia suggested that laws requiring bicyclists to wear helmets ... that part of the reason for the controversial conclusion is that, while helmets have ...
(Date:11/27/2015)... PITTSBURGH, PA (PRWEB) , ... November 27, 2015 ... ... to be a safe and convenient way to dispense prescription medications at home, ... safe and effective way to monitor and dispense prescription medications. In doing so, ...
(Date:11/27/2015)... ... 27, 2015 , ... ProSidebar: Fashion is a set of 30 ... ProSidebar: Fasion, video editors can easily add an informative sidebar to any FCPX production. ... Utilize presets featuring self-animating drop zones, lines, bars, and text with the ease of ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... "Self Administration of High Viscosity Drugs" report ... has announced the addition of the "Self ... their offering. --> Research and Markets ... the "Self Administration of High Viscosity Drugs" ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Surface Marker Testing Market: Supplier Shares, ... their offering.  --> ... the  "2016 Future Horizons and Growth ...
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
Breaking Medicine Technology: